In a groundbreaking study led by Jie Sun, PhD, from the UVA School of Medicine, researchers have unveiled a significant connection between severe respiratory infections and a heightened risk of lung cancer years later. The study emphasizes the importance of monitoring patients recovering from severe cases of COVID-19, influenza, or pneumonia, as early detection of lung cancer could dramatically improve treatment outcomes.
Dr. Sun, co-director of UVA's Carter Center and a member of the Division of Infectious Diseases and International Health, stated, "A severe bout of COVID or flu can leave the lungs in a prolonged state of inflammation, which facilitates cancer development." Fortunately, the study indicates that vaccination can mitigate these detrimental changes associated with cancer growth.
Impact of Severe Infections on Lung Health
Respiratory diseases like influenza and COVID-19 are prevalent causes of lung damage, yet the long-term implications for cancer risk remain poorly understood. To investigate this, Sun and his team examined the effects of severe lung infections in both mice and human subjects.
The results were compelling. Mice subjected to severe lung infections exhibited a greater likelihood of developing lung cancer later in life. Correspondingly, human data indicated that individuals hospitalized for COVID-19 had a notably higher rate of lung cancer diagnoses. Specifically, there was a 1.24-fold increase in lung cancer incidence among these patients, independent of smoking status or other health conditions.
Dr. Jeffrey Sturek, MD, PhD, a collaborator on the study, highlighted the implications for patient monitoring post-infection, suggesting, "Just as we monitor high-risk smokers with CT scans for lung cancer, we may need to adopt similar vigilance for those recovering from severe respiratory infections."
Understanding Immune Changes
The research also delved into the underlying mechanisms, revealing that severe infections cause notable alterations in immune cells, particularly neutrophils and macrophages, which typically protect the lungs. After infection, some neutrophils begin to behave abnormally, fostering a persistent inflammatory environment conducive to tumor growth.
Vaccination as a Protective Measure
Encouragingly, the study found that prior vaccination significantly reduced the lung changes associated with cancer risk. The increased cancer risk was primarily observed in individuals who experienced severe COVID-19, while those with mild infections showed a slight decrease in lung cancer incidence.
With millions globally enduring long-term effects from severe respiratory infections, this research underscores the need for enhanced lung cancer surveillance, particularly for those with a history of smoking. The findings advocate for a proactive approach in monitoring and potential preventive strategies against lung cancer linked to prior infections.
Future Directions in Lung Health
Sun and his team aspire to refine methods for identifying patients at greater risk of lung cancer following severe infections. Early detection could facilitate timely interventions, ultimately improving patient outcomes. This study not only aims to enhance understanding of cancer risk post-infection but also reinforces the broader benefits of vaccination in safeguarding long-term lung health.
